Dr. Georgios Spentzouris, MD

Dr. Spentzouris practices at NYU Faculty Group Practice in Mineola, New York.

Dr. Spentzouris' NPI, 1780902171, was assigned on May 10, 2010. Dr. Spentzouris holds New York license 276919.

Dr. Spentzouris' primary practice is NYU Faculty Group Practice, at 200 Old Country Rd, Mineola, NY 11501 in Nassau County. The practice phone is (877) 648-2964.

Dr. Spentzouris' primary practice is NYU Faculty Group Practice in Mineola, New York. Dr. Spentzouris is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Spentzouris to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spentzouris practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Spentzouris' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Spentzouris is licensed in New York.

CMS data shows 1,853 Medicare services from Dr. Spentzouris across 18 procedure codes in 2024, for 940 Medicare patients. Medicare paid $287,114 for them.

CMS counts 940 Medicare patients who saw Dr. Spentzouris in 2024. The largest group is 65 to 74, with 369 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spentzouris' median patient age at 71, with 56% women.

In 2024, Dr. Spentzouris wrote 590 Medicare Part D claims for 247 patients. 92% of them were for generic drugs. CMS names the drug for 507 of them, across 7 drugs with 11 or more claims each, at $39,321 in total drug cost. In 2023, CMS named 305 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Spentzouris for performance year 2024, reported as part of a group. Dr. Spentzouris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Spentzouris as offering telehealth. CMS counts 57 procedures of leg revascularization (restoring blood flow) by Dr. Spentzouris, more than 96% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Spentzouris, published from 2011 to 2022. 2014 was the busiest year, with 3. The most frequent topics are Anticoagulants. Dr. Spentzouris has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Spentzouris' most frequent co-authors are Antonios Gasparis, MD, Apostolos K. Tassiopoulos, MD and George L. Hines, MD.

CMS Open Payments shows 200 general payments to Dr. Spentzouris from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Medtronic Vascular, Inc. paid the most, $11,755.